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1. Synthesis and characterization of carbon nanotubes: 
Multi-walled carbon nanotubes were prepared by catalytic decomposition of methane (P. Chen, H. B. 
Zhang, G. D. Lin, Q. Hong, K. R. Tsai, Carbon 1997, 35, 1495-1501) at the University of Xiamen and purified 
by treatment with HNO3. The nanotubes were characterized by Raman spectroscopy (Figure S1) and X-ray 
photoelectron spectroscopy (Figure S2). 
 
 
Figure S1: Raman of the purified CNT (ex. 514 nm)  
 
 
Figure S2: XPS of the purified CNT 
 
2. Assembly of the CNT-gold nanohybrid and characterization: 
Step 1: Amphiphilic DANTA (20 mg) was dissolved in 2 mL of 25 mM pH 8 aqueous Tris-buffer before 
multiwalled carbon nanotubes (50 mg) were added. The dispersion was sonicated and the stable 
suspension transferred into two tubes. The tubes were centrifuged at 5000×g and the supernatants were 
collected. The latter were centrifuged at 15000×g for 45 min. The supernatant was discarded and the 
pellets taken in buffer and centrifuged again at 15000×g for 45 min. The pellets were finally resuspended in 
1.5 mL of buffer and submitted to UV irradiation at 254 nm for 6 h. 
Step 2: After polymerization, the buffer volume was adjusted to 1.5 mL. The suspension was stirred in the 
presence of the cationic polymer PDADMAC (700 µL of a 20% water solution) for 1 h. The ensuing 
centrifugation at 15000×g for 30 min permitted to get rid of the polymer in excess. The pellets were taken 
in 2 mL of buffer. This operation was repeated twice using the buffer solution and two more times using 
pure water. 
Step 3: The final pellets were resuspended in 1 mL of water. 50 L of the latter suspension was transfered 
to Eppendorf tubes (× 20). To each tube was added 1 mL of a 1 mM colloid suspension of the gold 
nanoparticles (D. G. Duff, A. Baiker, P. P. Edwards. Langmuir 1993, 9, 2301-2309) and the mixture was 
vortex-stirred at room temperature for 1 min every 30 min (during 4 h). The suspension was then 
centrifuged at 3000×g for 5 min. The supernatant was discarded and 1 mL of a fresh gold colloid suspension 
was added. The same process was repeated two more times. The pellets were washed 3 times by 
centrifugation/redispersion in water. The 20 pellets were combined and 4 mL of water was finally added. 
Gold concentration of the aqueous suspension was assessed by ICP-MS, [Au] = 3.4 mM. The AuCNT 
nanohybrid was further characterized by higher resolution transmission electron microscopy (TEM, Figure 
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S3), X-ray photoelectron spectroscopy (XPS, Figure S4), energy-dispersive X-ray spectroscopy (EDX, Figure 
S5), and thermogravimetric analysis (TGA, Figure S6).  
 
Figure S3: Higher resolution TEM of AuCNT 
 
 
Figure S4: Narrow scan XPS analysis of AuCNT 
 
Figure S5: EDX spectrum of AuCNT 
 
Figure S6: TGA of AuCNT (scan rate 5 °C/min) 
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3. General procedure for the direct oxidation of 1,4-dihydropyridines:  
The preparation of 2a is given as a representative example. To a solution of 1,4-dihydropyridine 1a (25 mg, 
0.1 mmol) in CHCl3/H2O 3:1 (2 mL), was added AuCNT (3.4 mM aqueous suspension, 145 µL, 0.5 mol%). The 
reaction mixture was stirred at room temperature under oxygen atmosphere for 11 h. After completion of 
the reaction (confirmed by TLC), the catalyst was removed by filtration and the aqueous phase was 
extracted with CHCl3
 (3 × 2 mL). The combined organic layer was dried over Na2SO4, filtered, and 
concentrated under vacuum to afford the pure product in 99% yield.  
 
4. General procedure for the co-catalytic oxidation of C-4 sustituted 1,4-dihydropyridines:  
Dihydropyridine 1f (33 mg, 0.1 mmol), 2,5-dichloro-1,4-benzoquinone 5 (3.5 mg, 0.02 mmol) and AuCNT 
(3.4 mM aqueous suspension, 290 µL, 1 mol%) were stirred in a biphasic mixture of CHCl3 (1.5 mL) and H2O 
(0.5 mL) at room temperature for 36 h under oxygen atmosphere. The catalyst was removed by filtration 
and the aqueous phase was extracted with CHCl3 (3 × 2 mL). The combined organic layer was dried over 
Na2SO4, filtered, and concentrated under vacuum. The residue was subjected to column chromatography 
(silica gel, cyclohexane/ethyl acetate) to afford the desired product 2f (78%).  
 
5. Recycling experiment:  
To a solution of 1,4-dihydropyridine 1a (25 mg, 0.1 mmol) in CHCl3/H2O 3:1 (2 mL), was added AuCNT (3.4 
mM aqueous suspension, 145 µL, 0.5 mol%). The reaction mixture was stirred at room temperature under 
oxygen atmosphere and the progress of the reaction monitored by TLC. After 11 h of reaction, the catalyst 
was recovered by centrifugation and the supernatant was worked up as described in the corresponding 
procedure to afford pure product 2a.  The recovered catalyst was washed with water and reused in 
subsequent oxidation reactions. This process was repeated over 5 consecutive cycles and showed no 
significant decrease in yields of oxidized product 2a (Table 2).  
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6. Spectral data for compounds 2a-j: 
 
2a: 1H NMR (400 MHz, CDCl3) δ (ppm) 8.63 (s, 1H), 4.40 (q, J = 8 
Hz, 4H), 2.85 (s, 6H), 1.42 (t, J = 8 Hz, 6H); 13C NMR (100 MHz, 
CDCl3) δ (ppm) 165.9, 162.2, 140.9, 123.0, 61.4, 24.9, 14.3. 
 
2b: 1H NMR (400 MHz, CDCl3) δ (ppm) 8.25 (s, 1H), 2.78 (s, 6H), 
2.64 (s, 6H); 13C NMR (100 MHz, CDCl3) δ (ppm) 199.2, 160.2, 
137.8, 130.1, 29.3, 24.9. 
 
2c: 1H NMR (400 MHz, CDCl3) δ (ppm) 8.77 (s, 1H), 6.11-6.01 (m, 
2H), 5.44 (d, J = 16 Hz, 2H), 5.34 (d, J = 8 Hz, 2H), 4.85 (d, J = 4 Hz, 
4H), 2.88 (s, 6H); 13C NMR (100 MHz, CDCl3) δ (ppm) 165.4, 162.6, 
141.0, 131.7, 122.7, 118.8, 65.9, 24.9. 
 
2d: 1H NMR (400 MHz, CDCl3) δ (ppm) 8.62 (s, 1H), 4.41 (q, J = 8 
Hz, 4H), ), 3.21 (q, J = 8 Hz, 4H), 1.42 (t, J = 8 Hz, 6H), 1.32 (t, J = 8 
Hz, 6H); 13C NMR (100 MHz, CDCl3) δ (ppm) 166.8, 166.1, 141.1, 
122.6, 61.4, 30.4, 14.2, 13.8.  
 
 
2e: 1H NMR (400 MHz, CDCl3) δ (ppm) 8.74 (s, 1H), 4.40 (q, J = 8 
Hz, 2H), ), 3.04 (s, 2H), 2.89 (s, 3H), 2.57 (s, 2H), 1.42 (t, J = 8 Hz, 
3H), 1.13 (s, 6H); 13C NMR (100 MHz, CDCl3) δ (ppm) 197.2, 165.8, 
164.6, 164.3, 137.1, 124.9, 124.5, 61.5, 51.9, 46.4, 32.9, 28.3, 
25.2, 14.3, 1.0. 
 
2f: 1H NMR (400 MHz, CDCl3) δ (ppm) 7.39-7.37 (m, 3H), 7.29-
7.26 (m, 2H), 4.02 (q, J = 8 Hz, 4H), ), 2.62 (s, 6H), 0.92 (t, J = 8 Hz, 
6H); 13C NMR (100 MHz, CDCl3) δ (ppm) 167.9, 155.4, 146.3, 
136.5, 128.5, 128.1, 128.0, 127.8, 127.0, 61.4, 22.8, 13.6. 
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2g: 1H NMR (400 MHz, CDCl3) δ (ppm) 7.21 (d, J=12Hz , 2H), 6.91 
(d, J = 8 Hz , 2H), 4.07 (q, J = 8 Hz, 4H), ), 3.84 (s, 3H), 2.60 (s, 6H), 
1.00 (t, J = 8 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ (ppm) 168.1, 
159.8, 155.1, 145.6, 129.4, 128.6, 127.4, 113.6, 61.4, 55.3, 22.7, 
13.8. 
 
2h: 1H NMR (400 MHz, CDCl3) δ (ppm) 7.26-7.23 (m, 2H), 7.11-
7.07 (m, 2H), 4.06 (q, J = 8 Hz, 4H), ), 2;61 (s, 6H), 0.99 (t, J = 8 Hz, 
6H); 13C NMR (100 MHz, CDCl3) δ (ppm) 167.7, 164.1, 155.4, 
145.5, 132.4, 130.1, 127.1, 115.1, 61.5, 22.8, 13.7. 
 
2i: 1H NMR (400 MHz, CDCl3) δ (ppm) 4.43 (q, J = 8 Hz, 4H), 2.53 
(s, 6H), 2.29 (s, 3H), 1.41 (t, J = 8 Hz, 6H); 13C NMR (100 MHz, 
CDCl3) δ (ppm) 168.3, 154.8, 142.2, 127.7, 61.6, 22.7, 16.9, 14.1. 
 
2j: 1H NMR (400 MHz, CDCl3) δ (ppm) 7.51 (s, 1H), 6.65 (d, J = 4 
Hz, 1H), 6.50-6.49 (m, 1H), 4.30 (q, J = 8 Hz, 4H), ), 2.59 (s, 6H), 
1.24 (t, J = 8 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ (ppm) 168.2, 
155.7, 144.0, 140.9, 133.9, 124.9, 111.9, 61.9. 22.6, 14.0. 
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7. 1H and 13C spectra of compounds 2a-j: 
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